- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03497091
Retrospective Review of Amino Acid Formula Use at a Children's Center
November 18, 2019 updated by: Nestlé
This is a retrospective review of data documented in medical records.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This is a retrospective review of data documented in medical records of patients consuming an amino-acid based enteral formula at a pediatric care facility in the United States.
Study Type
Observational
Enrollment (Actual)
23
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73008
- Children's Center for Rehabilitation Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The population studied retrospectively will be children in a pediatric feeding center consuming an amino acid-based enteral fomula and meeting the inclusion/ exclusion criteria.
Description
Inclusion Criteria:
- Consuming or with a history of consuming an amino acid-based formula
Exclusion Criteria:
- Medical records lacking information on consumption of an amino acid-based formula
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Enteral Tube fed children
Enteral Formula
|
Enteral Feeding with an amino acid-based formula
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Documented indication for formula use
Time Frame: Up to 12 months before formula switch
|
Medical diagnosis
|
Up to 12 months before formula switch
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body weight
Time Frame: 12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
|
Body weight in kilograms
|
12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
|
Length/height
Time Frame: 12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
|
Length or height (based on age) in centimeters
|
12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
|
Formula volume consumption
Time Frame: 12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
|
Average of 7 days
|
12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
|
Stool frequency
Time Frame: 12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
|
Average of 7 days
|
12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
|
Stool consistency
Time Frame: 12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
|
Average of 7 days
|
12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
|
Vomiting
Time Frame: 12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
|
Average of 7 days
|
12, 6 months prior to formula switch, at formula switch, and 6, 12 months post switch
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 15, 2018
Primary Completion (Actual)
December 31, 2018
Study Completion (Actual)
January 31, 2019
Study Registration Dates
First Submitted
April 5, 2018
First Submitted That Met QC Criteria
April 5, 2018
First Posted (Actual)
April 13, 2018
Study Record Updates
Last Update Posted (Actual)
November 19, 2019
Last Update Submitted That Met QC Criteria
November 18, 2019
Last Verified
November 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 17.10.US.HCN
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Enteral Feeding Intolerance
-
Sohag UniversityRecruitingEnteral Feeding IntoleranceEgypt
-
Brno University HospitalRecruitingEnteral Feeding IntoleranceCzechia
-
Mayo ClinicRecruiting
-
The University of Texas Health Science Center at...Avanos MedicalCompleted
-
Brno University HospitalMasaryk UniversityRecruiting
-
Boston Children's HospitalRecruitingEnteral Feeding IntoleranceUnited States
-
Ain Shams UniversityFuture University in EgyptCompletedEnteral Feeding IntoleranceEgypt
-
NestléCompletedEnteral Feeding IntoleranceCanada
-
Lyric PharmaceuticalsCompletedEnteral Feeding Intolerance (EFI)United States, Spain, Netherlands
-
Hospices Civils de LyonCompletedMechanical Ventilation Complication | Enteral Feeding IntoleranceFrance
Clinical Trials on Enteral Formula
-
Brno University HospitalRecruitingEnteral Feeding IntoleranceCzechia
-
Hospital Moinhos de VentoCompleted
-
Tungs' Taichung Metroharbour HospitalCompletedCritical Illness | Enteral NutritionTaiwan
-
NestléCompleted
-
NestléCompleted
-
Société des Produits Nestlé (SPN)Completed
-
NestléCompletedEnteral Feeding IntoleranceCanada
-
NestléCompletedCritically Ill ChildrenUnited States